Vlad Coric - 01 Mar 2023 Form 3 Insider Report for Revance Therapeutics, Inc.

Role: Director
Signature: /s/ Dwight Moxie, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 03 Mar 2023, 15:31:39 UTC
Previous filing: 01 Nov 2022
Next filing: 05 May 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24, Power of Attorney, is attached.